Patent · US Active

Bortezomib esters and formulations thereof

US9206229B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

CHEMI S.P.A. · IT

Inventors

Stefano Turchetta · Roma, IT
Maurizio Zenoni · Paullo, IT
Umberto Ciambecchini · Roma, IT
Paolo Brandi · Patrica, IT
Vincenzo De Sio · Patrica, IT
Giorgio Berardi · Patrica, IT

Key dates

Filing date	Aug 1, 2013
Grant date	Dec 8, 2015
Priority date	—
Expiry date	Aug 1, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Bortezomib esters with tartaric acid wherein the molar ratio between bortezomib and tartaric acid is 2:1 and formulations containing them are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.